Company profile
Allegro Biotech company profile
Allegro was founded in 2021 with the ultimate vision to augment humanity and prolong life, engineering the body atom-by-atom, blending nanotech and biotech. The company developed a promising nanotechnology platform to build therapeutic nanoparticles for orthopaedics, neuroscience, and chronic degenerative diseases. Allegro brings Xyletra to the market, the world's first disease-modifying treatment for osteoarthritis, which stops the degenerative process and alleviates pain with a year-long effect on a single shot administration.
Business identity
- Website
- https://allegro.bio/
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Founded
- 2021-04-21
Headquarters
- Headquarters
- Ligny, Wallonia, Belgium
- Postal code
- 4000
- Country code
- BE
- Continent
- Europe